U.S. General Merchandise and Department Stores Stock News

HBT Financial (HBT) stock has been drawing attention after recent market performance placed the regional bank in focus for investors looking at US community banking exposure and income focused financials. See our latest analysis for HBT Financial. Recent trading has been constructive for HBT Financial, with the share price gaining 9.78% over the past month and 27.46% year to date, while the 1 year total shareholder return of 33.87% and 5 year total shareholder return of 129.36% point to...

Coty (COTY) has drawn investor attention after agreeing to transition the Gucci Beauty license back to Kering for about $400 million, and has also seen its stock react to improving US consumer sentiment data. See our latest analysis for Coty. For context, Coty’s recent 1 month share price return of 37.37% and 7 day move of 16.52% mark a sharp rebound from a year to date share price decline of 16.08%. The 1 year total shareholder return is down 46.95% and the 3 year total shareholder return is...

Molina Healthcare's stock has rallied strongly in the short term, yet the longer three year return is still deeply negative and the broader valuation checks lean expensive. This raises the question of how much of the Illinois Medicaid contract win is already reflected in the current price. Over the past three years, Molina Healthcare shares have declined 29.2%, which suggests that the recent strength is working off a weak longer term base rather than building on steady gains. The newly...

AllianceBernstein Holding (AB) expanded its ETF platform to 23 U.S. funds with more than $19 billion in assets, after converting seven mutual funds to ETFs, giving taxable investors more options for managing capital gains tax impacts. See our latest analysis for AllianceBernstein Holding. AllianceBernstein Holding’s recent ETF conversions sit against a share price of $37.9, with a 1 month share price return of 4.81% but a year to date share price return that is down 1.92%, while the 3 year...

Stewart Information Services (STC) has drawn fresh attention after Stewart Title acquired a majority interest in Rattikin Title Company, a long-established Texas title agency with deep roots in the Fort Worth and North Texas region. See our latest analysis for Stewart Information Services. Against this backdrop, Stewart Information Services has seen the share price gain 9.9% over the past month and 6.6% over the past quarter. The 1 year total shareholder return of 27% and 3 year total...

T-Mobile US (TMUS) has come under closer scrutiny after a more cautious fair value assessment, with investors weighing satellite competition, spectrum reallocation and new fraud prevention efforts in light of evolving wireless market structures. See our latest analysis for T-Mobile US. Over the past year, T-Mobile US has seen its share price under pressure, with the year to date share price return down 3.58% and the 1 year total shareholder return down 13.71%. However, the 3 year total...

ACADIA Pharmaceuticals has returned about 19.3% over the past five years, yet recent valuation checks still flag the stock as screening cheap relative to its fundamentals, even after a strong one month move and mixed shorter term performance. Over a 5 year window, ACADIA Pharmaceuticals has delivered a 19.3% total return, which points to a moderate long term payoff rather than an outsized winner so far. The recent positive opinion from the European Medicines Agency’s Committee for Medicinal...

Watsco stock sits in an awkward spot on valuation today, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to almost 30% upside while traditional market multiples paint it as expensive and the broader checks give it a low value score. Watsco has returned 45.3% over the past 5 years, which is a solid outcome that makes the current price level important to scrutinize. Expectations for steady cash generation can support the DCF view of upside. However, any pressure on...

Bausch + Lomb (BLCO) has drawn fresh attention after launching its EyeGility Inserter in the U.S., a preloaded intraocular lens delivery system for its enVista Aspire and upcoming Envy cataract lenses. See our latest analysis for Bausch + Lomb. Despite a 1-day share price return that declined 3.27% to around US$16.26 following the EyeGility news, Bausch + Lomb’s 30-day share price return of 9.42% and 1-year total shareholder return of 16.98% suggest improving momentum, even as the 3-year...

Five Below recently marked a major milestone by celebrating the grand opening of its 2,000th store at 299 Commerce Avenue in LaGrange, Georgia, featuring giveaways, games and a limited-edition Neon Squishy Dumpling for the first 200 customers. The company’s partnership with several metro-Atlanta Boys & Girls Clubs underscores how its rapid store expansion is being paired with local community investment aimed at enhancing kid-focused spaces. We’ll now examine how this 2,000th store milestone,...

Atlas Energy Solutions (AESI) recently moved from profitability to a net loss of about $50.3 million in fiscal 2025. This shift places its cost structure and future earnings path in sharper focus. See our latest analysis for Atlas Energy Solutions. Atlas Energy Solutions' share price has pulled back recently, with a 30 day share price return of down 12.5% and a 7 day share price return of down 2.2%. At the same time, the year to date share price return of 44.8% and 90 day share price return...

American Superconductor stock has delivered a very large 3 year return, yet the current valuation checks now point to a mixed picture rather than a clear bargain or clear overvaluation. Over the past 3 years, American Superconductor has returned about 3.5x an initial investment, which makes the recent pullback especially relevant for anyone reassessing the stock. Future revenue and cash flow expectations can support the current share price, but any disappointment in execution or timing may...

Regulatory shock puts Edwards Lifesciences stock under a sharper lens The Federal Trade Commission’s record $12 million penalty tied to Edwards Lifesciences (EW) acquisition of JC Medical, along with new restrictions on future TAVR AR deals, has pushed the stock’s regulatory risk profile into sharper focus. See our latest analysis for Edwards Lifesciences. Since the FTC action, Edwards Lifesciences’ recent 1 day share price return of 2.4% and 7 day return of 7.03% show selling pressure...

Recently, Expeditors International of Washington attracted favorable attention as analysts raised earnings estimates and awarded it a strong Momentum Style Score and an improved Zacks Rank, citing resilient business performance. An interesting angle is how the company’s ability to adjust freight routing and pricing amid rising rates has reinforced confidence in its cash flow resilience. With this backdrop and Expeditors’ improved earnings outlook, we’ll now examine how these developments...

Willdan Group, Inc. recently announced it has been selected by Encina Wastewater Authority for a US$31,000,000 design-build contract to deliver a renewable cogeneration project that uses wastewater-derived biogas to produce on-site electricity and enhance plant resilience. This award highlights Willdan’s capabilities in integrating biogas conditioning, low-emission generation, emissions reduction upgrades, and battery storage with microgrid controls for complex infrastructure clients. We’ll...

Shirofune has launched an integration with Walmart Connect, allowing advertisers to manage Walmart campaigns within its platform. The integration is aimed at automating, centralizing, and optimizing retail media campaigns across Walmart and other digital channels. This development expands Walmart's retail media capabilities for brand partners using NasdaqGS:WMT's advertising network. Walmart, traded as NasdaqGS:WMT, is adding another tool to its retail media offering through Shirofune's new...

Earlier this week, the American Academy of Orthopaedic Surgeons launched an online Pain Management Resource Center to support clinicians and patients across the full orthopaedic care pathway, developed with founding partners Curonix, Pacira BioSciences, Vertex Pharmaceuticals and Viatris. Viatris’ role as a founding partner in this comprehensive pain education initiative underscores its focus on supporting musculoskeletal pain care beyond its product portfolio. We’ll now examine how Viatris’...

Recently, AXIS Capital Holdings’ strong track record of positive earnings surprises and a positive Zacks Earnings ESP of 3.82% highlighted rising analyst optimism ahead of its latest quarterly report. This pattern of earnings outperformance and upward estimate revisions has drawn attention to how consistently improving expectations can influence sentiment around the insurer’s near‑term performance. Next, we’ll examine how this positive earnings surprise momentum and analyst estimate...

Recent performance context for Nordson stock Without a single defining news event, Nordson (NDSN) still offers plenty for investors to assess, from its recent share performance to the scale of its operations in industrial and medical dispensing systems. The stock is down about 1.5% over the past day and roughly flat over the past month, while gaining around 0.8% over the past week, 2.5% over the past 3 months, and 20% year to date. See our latest analysis for Nordson. At a share price of...

Zebra Technologies has delivered a share price that is still down sharply over five years, yet its Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside from current levels, while market multiples look closer to fair. The stock has declined 51.3% over the past five years, which sets a cautious backdrop for any case that it is now undervalued. Fresh product launches in high-speed machine vision can support long term growth expectations, but the valuation still faces...

MGIC Investment (MTG) has drawn fresh attention after recent share price gains of 4.7% over the past week and 12.3% over the past month, prompting investors to reassess the mortgage insurer’s current valuation. See our latest analysis for MGIC Investment. Set against a 1 year total shareholder return of 19.58% and a 5 year total shareholder return of 143.64%, MGIC Investment’s recent share price strength suggests momentum has been building as investors reassess the balance between earnings,...

First Citizens BancShares (FCNC.A) is drawing attention as investors position ahead of its upcoming quarterly earnings report, with recent commentary highlighting a history of earnings surprises and a currently favorable Earnings ESP signal. See our latest analysis for First Citizens BancShares. First Citizens BancShares’ share price has edged higher over the past week and quarter, while the year to date share price return is slightly down and the 1 year total shareholder return is broadly...

Fabrinet’s share price has delivered very strong 5 year gains, yet its valuation signals are pulling in different directions, with the intrinsic value estimate pointing to a premium while earnings based multiples suggest the stock screens as cheap. Fabrinet has returned 418.7% over 5 years, setting a high bar for what investors may expect from the stock at today’s price. Expectations for continued cash generation can support the current valuation, but any disappointment in future revenue or...

Papa John’s recently reported softer-than-expected earnings and lower revenue, raising fresh questions about customer demand, restaurant traffic, and how effectively the company is managing its costs. These results shift attention to whether improvements in franchise economics, digital engagement, and tighter expense control can help Papa John’s regain operational momentum. Next, we’ll examine how weaker earnings and revenue, and the questions they raise about operating efficiency, may...